Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.87 USD | -4.01% | +8.15% | -31.92% |
02/05 | CUREVAC : A missed opportunity | |
26/04 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.09% | 670M | |
+22.16% | 46.4B | |
-1.70% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+9.96% | 26.01B | |
-19.33% | 19.52B | |
+29.38% | 12.43B | |
+0.06% | 12.18B | |
-0.64% | 12.13B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac Begins Early Stage Portion of Investigational Vaccine Trial